To celebrate Open Access Week 2020, Open Pharma teamed up with NetworkPharma and MedComms Networking to host an expert panel discussion on multi-stakeholder perspectives on open access publishing of pharma-sponsored research.
Last Wednesday, Chris Winchester (CEO of Oxford PharmaGenesis and co-founder of Open Pharma) joined Peter Llewellyn at NetworkPharma and MedComms Networking to facilitate a lively discussion on everything open access. The multi-stakeholder panel included perspectives from pharma, publishing and patient advocacy from Valérie Philippon (Takeda), Gavin Sharrock (Wiley) and Durhane Wong-Rieger (Canadian Organization for Rare Disorders), respectively. For those who missed it, a recording of the discussion is available on demand for free at NetworkPharma.tv and on YouTube.
The discussion was directed and informed by questions from the Zoom chat box and through the Q&A function. Topics largely fell into three overall categories:
- the benefits of open access publishing and improving equity
- open access mandates and barriers to implementing open access
- accessibility and plain language summaries.
Keep an eye out for future blog posts covering each of these topics in more depth!
